Suppr超能文献

各种肩部手术中术前使用阿片类药物的临床结局:一项系统评价

Clinical Outcomes Associated With Preoperative Opioid Use in Various Shoulder Surgical Procedures: A Systematic Review.

作者信息

Devano Dan Michael J, Smith John-Rudolph, Houck Darby A, McCarty Eric C, Seidl Adam J, Wolcott Michelle L, Frank Rachel M, Bravman Jonathan T

机构信息

Division of Sports Medicine and Shoulder Surgery, Department of Orthopedics, School of Medicine, University of Colorado, Aurora, Colorado, USA.

出版信息

Orthop J Sports Med. 2021 Apr 21;9(4):2325967121997601. doi: 10.1177/2325967121997601. eCollection 2021 Apr.

Abstract

BACKGROUND

The impact of preoperative opioid use on outcomes after shoulder surgery is unknown.

PURPOSE/HYPOTHESIS: To examine the role of preoperative opioid use on outcomes in patients after shoulder surgery. We hypothesized that preoperative opioid use in shoulder surgery will result in increased postoperative pain and functional deficits when compared with nonuse.

STUDY DESIGN

Systematic review; Level of evidence, 3.

METHODS

A systematic review was performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Included were all English-language studies comparing clinical outcomes of shoulder surgery in patients who used opioids preoperatively (opioid group) as well as patients who did not (nonopioid group) with a minimum follow-up of 1 year. Outcomes included range of motion, American Shoulder and Elbow Surgeons score, Constant-Murley score, and visual analog scale for pain. Study quality was evaluated with the Modified Coleman Methodology Score and the MINORS score (Methodological Index for Non-randomized Studies).

RESULTS

Included were 5 studies (level 2, n = 1; level 3, n = 4): Two studies were on total shoulder arthroplasty, 2 on reverse total shoulder arthroplasty, 1 on both, and 1 on arthroscopic rotator cuff repair. There were 827 patients overall: 290 in the opioid group (age, 63.2 ± 4.0 years [mean ± SD]; follow-up, 38.9 ± 7.5 months) and 537 in the nonopioid group (age, 66.0 ± 4.7 years; follow-up, 39.5 ± 8.1 months). The opioid group demonstrated significantly worse pre- and postoperative visual analog scale and Constant-Murley score pain scores as compared with the nonopioid group. Mean American Shoulder and Elbow Surgeons scores were significantly lower in the opioid group at pre- and postoperative time points as compared with the nonopioid group ( < .05 for all). However, both groups experienced similar improvement in outcomes pre- to postoperatively. One study showed that the opioid group consumed significantly more opioids postoperatively than the nonopioid group and for a longer duration ( < .05). The overall mean Modified Coleman Methodology Score and MINORS score were 64.2 ± 14 and 15.8 ± 1.0, respectively.

CONCLUSION

Opioid use prior to various shoulder surgical procedures negatively affected postoperative pain and functionality. Although the opioid group showed significantly worse scores postoperatively, the groups experienced similar improvements.

摘要

背景

术前使用阿片类药物对肩部手术后结局的影响尚不清楚。

目的/假设:探讨术前使用阿片类药物对肩部手术后患者结局的作用。我们假设,与未使用阿片类药物相比,肩部手术术前使用阿片类药物会导致术后疼痛加剧和功能缺陷。

研究设计

系统评价;证据等级,3级。

方法

按照PRISMA(系统评价与Meta分析的首选报告项目)指南进行系统评价。纳入所有比较术前使用阿片类药物患者(阿片类药物组)和未使用阿片类药物患者(非阿片类药物组)肩部手术临床结局的英文研究,最小随访时间为1年。结局指标包括活动范围、美国肩肘外科医师评分、Constant-Murley评分和疼痛视觉模拟量表。采用改良科尔曼方法评分和MINORS评分(非随机研究的方法学指标)评估研究质量。

结果

纳入5项研究(2级,n = 1;3级,n = 4):2项研究涉及全肩关节置换术,2项涉及反式全肩关节置换术,1项涉及两者,1项涉及关节镜下肩袖修复术。总共有827例患者:阿片类药物组290例(年龄,63.2±4.0岁[均值±标准差];随访时间,38.9±7.5个月),非阿片类药物组537例(年龄,66.0±4.7岁;随访时间,39.5±8.1个月)。与非阿片类药物组相比,阿片类药物组术前和术后的疼痛视觉模拟量表评分和Constant-Murley评分明显更差。与非阿片类药物组相比,阿片类药物组术前和术后时间点的美国肩肘外科医师平均评分明显更低(所有P值均<0.05)。然而,两组术后结局的改善情况相似。一项研究表明,阿片类药物组术后消耗阿片类药物的量明显多于非阿片类药物组,且持续时间更长(P<0.05)。总体平均改良科尔曼方法评分和MINORS评分分别为64.2±14和15.8±1.0。

结论

在各种肩部手术前使用阿片类药物对术后疼痛和功能有负面影响。尽管阿片类药物组术后评分明显更差,但两组的改善情况相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73a3/8072861/fbdcd7df3179/10.1177_2325967121997601-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验